How Multiple Platform Marketing Spread Rare Disease Awareness

Cambridge BioMarketing raised awareness and funds through multiple platforms

by Alexander Neely | April 25, 2017 | This article originally appeared in DMN

A recognizable cause or disease does not automatically correlate to funds raised or present advocacy, especially in the crowded, nonprofit landscape. Nonprofit organizations representing well-known issues still must work hard to spread awareness and encourage donations.

Rare diseases have it even harder. How do nonprofit organizations and their agencies create awareness? This is the all-too-real issue Cambridge BioMarketing, a rare disease and specialty communications agency, encountered when creating a new campaign.

Empower, educate, and activate

In 2001, Everyday Health purchased Cambridge BioMarketing for $33 million, providing additional funding to help the agency develop public relations campaigns for orphan and rare biotech companies.

How do you get others aware of this space though? How do spread awareness and raise funds for such a space in the crowded nonprofit sector? The agency decided to wrap up all of its individual issue work into one campaign, #SupportTheSearch

Support the search

Cambridge BioMarketing decided to launch a marketing campaign, where rare disease advocates, patients, and caregivers—as well as the general public, would have the opportunity to spread the message about how devastating rare diseases are, but how uncommon treatments for them are, resulting in the need for more research.

The marketing campaign, according to Mike Hodgson, Chief Creative Officer at Cambridge BioMarketing, required a three-pronged approach – social media, media relations, email nurture and billboards – to adequately spread the word.

“The team looked to generate awareness and engagement on social by targeting local influencers as well as advocates, caregivers and the public and encouraging shares across their networks,” says Hodgson.

An added social media incentive was developed by Cambridge BioMarketing, as each time #SupportTheSearch was mentioned on social, the company donated to Global Genes, NORD, and the Rare Disease United Foundation to help to raise funds for rare disease research.

The second tactic of media relations required Cambridge BioMarketing to reach out to and disseminate press releases to both regional and pharmaceutical trade media to cover the campaign. Lastly, the third prong, promotion strategy, stated Hodgson, was an effort by the company to focus on those people not on social media.

“The team activated an email nurture campaign to generate donations among clients and prospects to three main rare disease charities,” says Hodgson. “Images of the campaign were also broadcast across six Clear Channel electronic billboards on I-93 North and the Southeast Expressway, covering major commuting routes and reaching densely populated communities surrounding Boston.”

Rare to recognized

The #SupportTheSearch campaign ran from January 30, a soft-launch date, to February 28, also known as International Rare Disease Awareness Day.

During that time, #SupportTheSearch was mentioned in over 1,000 tweets focused on the Rare Disease Day, and on Facebook, almost 90,000 people talked about the campaign, which was classified as a Popular Search on the social network. On Instagram, over 120 posts were dedicated to #SupportTheSearch visual content.

Several influencers also tweeted about the campaign, including Boston Mayor Marty Walsh, former MA Representative Bob Coughlin, Global Genes, and others.

In total, the campaign received almost 1.5 million total impressions.

“We were pleasantly surprised to see the willingness of the public to support a cause so unique and so personal to a seemingly small number of people,” says Hodgson. “#SupportTheSearch made clear that the community, as well as the rare disease community, is passionate about advancing rare disease research.”

TRNDS 2017

University of Rochester
Saunders Research Building
Helen Wood Hall Auditorium
255 Crittenden Blvd
Rochester, NY 14642

Date: Friday, May 12, 2017
Time: 7:30am – 3:45pm

TRNDS Speakers

Plan Your Stay

Hilton Garden Inn
Rochester/University
Medical Center

30 Celebration Drive
Rochester, NY 14620

Phone: 585-424-4404

TRNDS News

  • New Grants will Accelerate Clinical Trials in Rare Neurological Disorders
    READ MORE
  • Neurogene Offers Access to Genetic Testing for Lysosomal Storage Disease
    READ MORE
  • NIH launches 5-year, $10 million study on acute flaccid myelitis
    READ MORE
  • Study refines ALS risk among first-degree relatives of patients with disease
    READ MORE
  • NCATS Director Warns of 'Poorly Understood Public Health Implications of Rare Diseases'
    READ MORE
  • Speeding Up Drug Discovery for Brain Diseases
    READ MORE
  • NIH-Funded Project Aims to Build a ‘Google’ for Biomedical Data
    READ MORE
  • Rare Disease Groups Seek Public Support to Renew Newborn Screening Act in Senate
    READ MORE
  • Jsyne Gershkowitz, Amicus Therapeutics, TRNDS 2019
    (Podcast) Get to know Jayne Gershkowitz, Chief Patient Advocate at Amicus Therapeutics
    READ MORE
  • PJ Brooks, NCATS, NIH, TRNDS
    Meet TRNDS 2019 Speaker PJ Brooks
    READ MORE
  • Rare Pediatric Disease PRVs: FDA Updates Guidance
    READ MORE
  • Batten Disease Study
    Neurogene Opens Natural History Study of CLN7, CLN5 Diseases at UT Southwestern
    READ MORE
  • C-Path and NORD Collaborate to Launch Rare Disease Data Platform
    READ MORE
  • TRNDS 2019 speaker Tauna Batiste, BDSRA
    Meet TRNDS Speaker Tauna Batiste
    READ MORE
  • HD Patients Prefer Less Invasive, No-Placebo Gene Therapy Trials
    READ MORE
  • Evidation & Eli Lilly Study Uses Apple Devices, Apps to Predict Cognitive Impairment
    READ MORE
  • 'Dr. Google' Helps Some Patients Diagnose a Rare Disease
    READ MORE
  • Antisense Drugs for HD, ALS & Prion Could Meet the Need for Brain Treatments
    READ MORE
  • Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome
    READ MORE
  • Netflix's Medical Investigation Docuseries 'Diagnosis'
    READ MORE
  • NIH All of Us Project Tops 270,000 Sign-ups
    READ MORE
  • FDA Cancer Office Taps Syapse for Real-world Evidence Development
    READ MORE
  • Gene Linked to Rare Neurological Disorder May Play a Role in Alzheimer’s
    READ MORE
  • Gene Therapy Developers Issue Principles for Human Genome Editing
    Gene Therapy Developers Issue Principles for Human Genome Editing
    READ MORE
  • Forget Single Genes: CRISPR Now Cuts & Splices Whole Chromosomes
    READ MORE
  • Benjjamin Schlatka MC10 TRNDS
    TRNDS Speaker Benjamin Schlatka, MC10
    READ MORE
  • TRNDS Danielle Edwards Jett Foundation
    TRNDS Speaker Danielle Edwards, Jett Foundation
    READ MORE
  • His daughter has a rare disorder. He’s developing a novel gene therapy.
    READ MORE
  • A Doctor Tested a New Treatment on Himself, Now it's Saving Other Lives
    READ MORE
  • Study Presents Clinical, Genetic Landscape of Pompe Disease
    READ MORE